This month saw BioCina officially open its new biologics manufacturing facility in Adelaide, Australia, flagging it as the only TGA, EMA, Health Canada and US-FDA approved commercial facility of its kind in the country.
Touchlight, a synthetic DNA producer, says it has received the first phase of planning approval for breaking ground on its new research and manufacturing facility in Hampton, UK.
VGXI, Inc, a provider of plasmid DNA manufacturing and development services, says multiple construction milestones have been reached for its new headquarters and manufacturing facility in Texas.
Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type (Adeno-Associated Virus, Adenovirus, and Lentivirus), by Indication (Cancer, Genetic Disorder, and Infectious Disease), by Workflow, by Application, by End User, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19New York, June 10, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report "Viral Vector & Plasmid DNA Manufacturing M
Charles River Laboratories will pay $292.5 million in cash for gene therapy CDMO Vigene Biosciences. The move will add viral vector and plasmid DNA manufacturing to Charles River’s cell and gene repertoire boosting its presence in a CMDO market valued at $2.5 billion globally and growing, the company said.